Euclises Pharmaceuticals is a St. Louis-based company specializing in the development of next-generation therapies that target clinically-proven cancer biology, with a focus on expanding the population of patients who will respond to Immuno-Oncology therapies and achieving new levels of efficacy.
With a dedicated team of experienced drug developers, Euclises is committed to preventing tumor immune evasion and disrupting the tumor microenvironment, offering safe and effective treatments for COX-2 driven cancers while maximizing anti-cancer efficacy through precise dosing.
Generated from the website